---
title: "ELOXX PHARMACEUTICALS INC (ELOXD.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/ELOXD.US/norm.md"
symbol: "ELOXD.US"
name: "ELOXX PHARMACEUTICALS INC"
parent: "https://longbridge.com/en/quote/ELOXD.US.md"
datetime: "2026-06-13T21:04:41.840Z"
locales:
  - [en](https://longbridge.com/en/quote/ELOXD.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ELOXD.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ELOXD.US/norm.md)
---

# ELOXX PHARMACEUTICALS INC (ELOXD.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q1 2025 |
| --- | --- | --- |
| EPS | -0.8565 | -4.94 |
| ROE | - | - |
| Revenue | - | - |
| Net income | -3.75M | -1.71M |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q1 2025 |
| --- | --- | --- |
| A&L | 8.50M | - |
| Leverage | -1.12 | - |
| BVPS | -16.44 | -71.22 |
| Turnover | - | - |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q1 2025 |
| --- | --- | --- |
| Operating CF | -5.45M | 1.20M |
| Investing CF | - | - |
| Financing CF | 7.03M | -865000.00 |
| Free CF | - | - |